MBOT Rasio cepet Microbot Medical Inc.

Microbot Medical Inc. (MBOT) develops compact surgical robots, providing clinics with recurring revenue through the sale of consumables. The company aims to expand the presence of the Liberty system in the US, capturing the high-tech equipment segment. The current metric stands at 18.61. This price chart complements data regarding preparations for the commercial launch of the first disposable IT platform and the acquisition of FDA certifications.

Strong clinician interest in robotic surgery creates a foundation for the capitalization of Microbot Medical Inc. (MBOT). The absolute trend of the quick ratio reflects the company's ability to instantaneously settle short-term obligations. This metric excludes illiquid inventories, pairing only cash and accounts receivable against current liabilities. Such a conservative approach confirms the business's financial stability as it establishes its market reputation.